EssilorLuxottica S.A.

Introduction & Episode Overview**

Picture this: nearly 30% of the global market share and represents almost a billion pairs of lenses and frames sold annually. One company controls how a third of humanity sees the world, from the prescription glasses worn by millions of children to the Ray-Ban Aviators that defined generations of cool. This isn't just market dominance—it's an empire built on the most fundamental of human needs: sight.

The numbers tell a story that would make any Silicon Valley unicorn envious. In 2023, the global revenue of EssilorLuxottica amounted to approximately 25.4 billion euros, and by 2024, the group reached €26.5 billion in full-year revenues. But this isn't a tale of overnight success or venture capital moonshots. It's the culmination of two European dynasties—one French, one Italian—that spent decades perfecting their crafts before joining forces to create what critics call a monopoly and what the company calls the future of vision.

The central question haunts every competitor, regulator, and consumer advocate: How did two companies from opposite sides of Europe—a French lens manufacturer founded in 1849 and an Italian frame maker started by an orphan in 1961—merge to create a vertically integrated colossus that controls everything from the factories that make your glasses to the stores that sell them, from the insurance that pays for them to the technology that will turn them into computers?

In 2017, EssilorLuxottica had nearly 150,000 employees and pro forma consolidated revenues would have reached approximately Euro 16 billion at the time of the merger announcement. Today, that workforce has grown to over 200,000 people across more than 150 countries, operating a business model so comprehensive that escaping its reach requires conscious effort.

This is the story of how vision became a luxury good, how medical devices became fashion statements, and how two visionaries—one who couldn't afford glasses as a child, the other who invented a lens that changed aging—built an empire that sees everything.

II. The Essilor Origins: French Precision & Progressive Vision (1849–2000)

The rain hammered against the windows of La Société des Lunetiers in 1959 as Bernard Maitenaz watched his father struggle with his bifocals. Frustrated with his father's bifocals, and determined to improve his father's life by improving his sight, Bernard, who was then a 33-year-old engineer at La Société des Lunetiers in 1959, took on the task of creating a lens that would provide presbyopes with comfortable vision at any distance. That frustration would spark a revolution that transformed how billions of people experience aging.

But Essilor's story begins much earlier. Essel (Société des Lunetteries) was founded in 1849 (then-called L'Association Fraternelle des Ouvriers Lunetteries) as a small network of eyeglass assembly workshops in Paris. It expanded in the late 19th and early 20th centuries by acquiring factories in nearby Parisian neighborhoods and Eastern France. Essel soon added frame design and trade to its activities. For over a century, it was a respectable but unremarkable player in French optics—until Maitenaz's breakthrough changed everything.

The first version of the lens was invented by Bernard Maitenaz and released in 1959, and was the first modern progressive lens to correct presbyopia. The Varilux wasn't just an incremental improvement; it was a fundamental reimagining of how corrective lenses could work. On March 2, 1951, Bernard Maitenaz deposited an envelope at the National Institute of Industrial Property in France which included four drawings and mechanical data that would make it possible to manufacture the modern-day progressive lens. On November 25, 1953, Essel submitted a first patent on his invention. After patents and calculations, this type of progressive lens appeared to be possible, but had yet to be manufactured. Maitenaz and his team began producing progressive lenses using a variety of different improvised techniques and by 1958, Essel had developed machinery capable of mass manufacturing them.

The market response was initially tepid. From sales of 6,000 lenses in 1959 to 2,000,000 in 1969, Varilux was becoming a successful venture, but the market still had some concerns regarding the adaptation time to the lens. Wearers complained about distortion, adaptation periods stretched weeks, and many opticians remained skeptical. But Maitenaz, who had graduated with degrees in engineering from both Arts et Métiers in 1946 and Ecole Supérieure d'Optique in 1947, possessed both the technical expertise and stubborn persistence to keep refining his invention.

The real transformation came through merger. At the start of 1969, two companies dominated the French ophthalmic lens market: Essel and Silor. Although both had created innovations of their own (Essel with Varilux and Silor with the Orma 1000 organic material), they were not major players on the international market. On January 1, 1972, Essel and Silor merged and formed Essilor. This wasn't just a business combination—it was the fusion of two complementary innovations that would define modern eyewear.

Under Maitenaz's leadership as CEO from 1981 to 1991, Essilor transformed from a French company into a global powerhouse. At the helm of the company between 1981 and 1991, he oversaw a period of major international growth, which turned Essilor into the world's leading lens manufacturer. The company didn't just sell lenses; it sold a vision of aging without compromise.

In 1993, Varilux Comfort was launched and became the world's best-selling progressive lens. By this point, Essilor had cracked the code: combine relentless R&D investment with global distribution and brand building. The company poured hundreds of millions annually into research, developing new coatings, materials, and designs that competitors couldn't match.

The numbers tell the story of dominance through innovation. To date, more than 700 million Varilux lenses have been sold since 1959. What started as one engineer's frustration with his father's bifocals had become the global standard for how humanity deals with presbyopia. But Essilor's ambitions extended far beyond progressive lenses—they were building the technology moat that would make them indispensable to any future partner.

↑ Back to Top

III. The Luxottica Story: From Orphanage to Oakley (1961–2007)

Leonardo Del Vecchio was born on 22 May 1935 in Milan, Italy to an impoverished family from Barletta, Southern Italy. His father was a street vendor of vegetables who died before his birth and his mother already had four other children; he grew up in an orphanage. The nuns at the Martinitt orphanage in Milan couldn't have imagined that the seven-year-old boy they took in would one day control how the world sees itself.

At fourteen, Leonardo left the orphanage to begin his working life. His first job involved apprenticing with a tool and die maker in Milan. He lost part of his left index finger during this period. The injury might have ended another person's ambitions, but for Del Vecchio, it was merely the first scar in a lifetime of battles.

The turning point came in 1961. In 1961, Leonardo got wind of an opportunity offered by a small town in northeast Italy called Agordo. To stimulate the population and local industry, Agordo was offering to give free land to anyone who opened a business. So that's what Leonardo decided to do. At 26 he moved to Agordo and launched a small factory to make eyeglass frame parts. Luxottica was founded in Agordo by Leonardo Del Vecchio in 1961 as a sunglasses manufacturer selling and branding under its own name.

What followed was a masterclass in vertical integration that would make Andrew Carnegie jealous. Del Vecchio quickly acquired numerous businesses in the pursuit of vertical integration, buying distribution companies rapidly and signing its first designer licensing agreement with Giorgio Armani. This Armani deal in 1988 wasn't just about making frames—it was about transforming eyewear from medical device to luxury good.

The company's appetite for acquisitions was insatiable. The company was listed in New York in 1990, and in Milan in December 2000, joining the MIB-30 (now S&P/MIB) index in September 2003. The listing enhanced the company's ability to acquire other brands, starting with Italian brand Vogue in 1990, Persol and US Shoe Corporation (LensCrafters) in 1995, Ray-Ban in 1999 and Sunglass Hut, Inc. in 2001.

The Ray-Ban acquisition deserves special attention. In 1999, Bausch & Lomb sold the brand to Italian eyewear conglomerate Luxottica Group for a reported $640 million. At the time, Ray-Ban was in terrible shape. In 1999, the brand was in a shambles, with its once-pioneering wares on sale for $19 at countless gas stations and convenience stores. And the quality was awful: Ray-Ban was using antiquated tooling and its frames were flimsy.

Del Vecchio saw what others missed: an iconic American brand that just needed Italian craftsmanship and distribution muscle. In 2000, Ray-Ban generated 252 million euros for Luxottica, or 10% of company sales. By 2014, that had risen more than eightfold to 2.065 billion euros, or 27% of Luxottica sales. Ray-Bay now commands 5% of the global eye wear market, and is the largest sunglasses brand, according to Euromonitor International data.

But the Oakley acquisition in 2007 revealed the darker side of Luxottica's power. In early 1996, Oakley had a pricing dispute with Italian company Luxottica, the world's largest eyewear manufacturers and retailers. Luxottica stopped carrying Oakley's products in their stores, including Sunglass Hut, and Oakley's stock market value declined 33%. Oakley had tried to dispute their prices because of Luxottica's large marketshare, and Luxottica responded by dropping Oakley from their stores, causing their stock price to drop, followed by Luxottica's hostile take over of the company.

They acquired Oakley in a US$2.1 billion deal in November 2007. What started as a pricing dispute ended with Oakley's founders walking away and Del Vecchio adding another crown jewel to his empire. Critics called it monopolistic behavior; Del Vecchio called it business.

By 2007, Luxottica wasn't just making glasses—it was setting the rules for an entire industry. The orphan from Milan had built a vertically integrated machine that controlled manufacturing, distribution, retail, and even insurance. The only thing missing was the technology to make the lenses themselves. For that, Del Vecchio would need a partner.

↑ Back to Top

IV. The Mega-Merger: Creating a €50 Billion Giant (2017–2018)

The January 2017 announcement landed like a meteor in the optical industry. In January 2017, Essilor and Luxottica announced the merger of their activities. After having received the necessary authorizations from the competition authorities of the United States, the European Union, Brazil, Canada and China, EssilorLuxottica was created on 1 October 2018.

This merger gives birth to a giant of the optical industry, generating a turnover of more than €16 billion and a market capitalization of €57 billion. The numbers were staggering, but the strategic logic was even more compelling. Essilor brought lens technology and innovation; Luxottica brought frames, brands, and retail distribution. Together, they could control the entire value chain from lab to consumer.

On a technical level, Essilor acquired Luxottica, though Luxottica founder and executive chairman Leonardo Del Vecchio became co-leader of the new conglomerate. This structure—technically an acquisition but practically a merger of equals—would prove combustible. Two titans of industry, both accustomed to absolute control, now had to share power.

The regulatory gauntlet was intense. Competition authorities worldwide scrutinized a deal that would create unprecedented concentration in the optical industry. All conditions precedent to the closing of the transaction have been satisfied, including approval by Essilor shareholders in May 2017, the hive-down of substantially all Essilor activities to Essilor International SAS (a wholly-owned subsidiary of Essilor) in November 2017 and clearance from all antitrust authorities whose authorization was a condition precedent to the closing of the transaction.

The promised synergies were enormous. EssilorLuxottica has the opportunity for significant value creation through revenue and cost synergies, which are overall anticipated to range from Euro 420 to Euro 600 million as a net impact in EBIT per annum in the medium term, then to accelerate in the longer run. Management painted a picture of innovation acceleration, with frames and lenses designed together for the first time, creating products impossible for separated companies to achieve.

But beneath the corporate speak and financial projections, a more fundamental transformation was occurring. This wasn't just two companies merging—it was the creation of a new kind of company entirely. Part manufacturer, part retailer, part technology company, part healthcare provider. The new entity will be worth around $50bn (£37bn), sell close to a billion pairs of lenses and frames every year, and have a workforce of more than 140,000 people.

Critics immediately raised alarms. How could one company control so much of how humanity sees without abusing that power? The company's response was consistent: the market remained competitive, innovation would accelerate, and consumers would benefit from better products at better prices. Whether that promise would be kept remained to be seen. What was certain was that the optical industry would never be the same.

↑ Back to Top

V. The Power Struggle: Del Vecchio vs. Sagnières (2018–2021)

The honeymoon lasted exactly as long as it took for the ink to dry on the merger documents. What followed was a corporate cage match that would make HBO's Succession look like a documentary.

Del Vecchio went on to state in a March 2019 interview with Le Figaro that Essilor CEO Hubert Sagnières "only listened to himself", and had cost the company up to €600 million in savings from the merger. The accusation wasn't just about money—it was about control, vision, and fundamentally different approaches to running a global empire.

Sagnières responded to Del Vecchio by accusing the Luxottica founder of attempting to take control of the newly formed conglomerate without offering "a premium to shareholders" of EssilorLuxottica. Del Vecchio further accused Sagnières of inexperience when running an eyewear company. The gloves were off, and the world's largest eyewear company was tearing itself apart from the inside.

The battle played out in boardrooms, press releases, and leaked comments to journalists. Del Vecchio, then in his mid-80s, showed the street fighter instincts that had carried him from orphanage to oligarch. Sagnières, representing the French establishment and Essilor's engineering culture, fought to preserve the merger-of-equals structure that had been promised.

Behind the personalities lay a fundamental strategic disagreement. Sagnières wanted to focus on Essilor's traditional strengths: innovation in lenses, expansion in emerging markets, and the healthcare aspects of vision correction. Del Vecchio saw the future in luxury brands, vertical integration, and the transformation of eyewear into the next computing platform.

The resolution came with shareholder revolt. Del Vecchio's camp gradually won over institutional investors who saw the merger's promised synergies evaporating in the leadership chaos. By 2020, the game was essentially over. Del Vecchio emerged victorious, appointing Francesco Milleri as CEO and Paul du Saillant as deputy CEO—both seen as his proteges.

Sagnières' departure marked the end of an era for Essilor and the beginning of Del Vecchio's final act. Del Vecchio died in June 2022, leaving $350 million in shares to Milleri. Even in death, Del Vecchio ensured his vision would continue, binding his successor to the company with golden handcuffs that would make departure financially impossible.

The power struggle cost the company more than just the €600 million Del Vecchio claimed. It cost time, momentum, and credibility. But it also clarified something essential: EssilorLuxottica would be run like Luxottica, with the aggression, vertical integration, and ambition that had built Del Vecchio's empire. The French precision would remain, but it would serve Italian ambition.

↑ Back to Top

VI. The GrandVision Acquisition: Retail Domination (2019–2021)

Just as the internal warfare was reaching its climax, EssilorLuxottica launched its most ambitious acquisition yet. EssilorLuxottica acquired a 75% stake in GrandVision for €28 per share, which would value the entirety of GrandVision at Euro 7.2 billion. GrandVision operated more than 7,000 stores globally, including Vision Express in the UK and For Eyes in the US.

Then COVID-19 struck. Stores closed, consumers stopped buying glasses, and what looked like a strategic masterstroke suddenly seemed like a potentially fatal overreach. GrandVision's management, seeing an opportunity to renegotiate or escape, began implementing defensive measures that EssilorLuxottica claimed breached their agreement.

What followed was a corporate drama involving arbitration in Geneva, accusations of bad faith on both sides, and a battle that would determine whether the deal would close at the original price, be renegotiated, or collapse entirely. The stakes were enormous—not just the €7.2 billion price tag, but the credibility of EssilorLuxottica's entire consolidation strategy.

The arbitration tribunal ultimately ruled that EssilorLuxottica could walk away from the deal without penalty, giving the company enormous leverage. But in a move that surprised many observers, the company decided to proceed. The strategic rationale of the transaction remains strong and unchanged, and after two years of efforts and relentless work, we are now ready to turn a page and start a new chapter of EssilorLuxottica's history, with GrandVision. In doing so, we will use the learnings and experience gathered over the past years to ensure GrandVision and its 37,000 talented employees are integrated successfully.

EssilorLuxottica today announces that it has completed its acquisition of a 76.72% ownership interest in GrandVision from HAL Optical Investments, a wholly-owned subsidiary of HAL Holding pursuant to the block trade agreement entered into with HAL on July 30, 2019. The acquisition closed on July 1, 2021, at the original price despite everything that had happened.

The regulatory approval came with conditions. Authorities required divestments of approximately 350 stores across Belgium, the Netherlands, and Italy—a small price for adding 7,000 stores to an already dominant retail network. The acquisition meant EssilorLuxottica now operated over 18,000 stores globally, creating a retail footprint that made it virtually impossible for any lens or frame manufacturer to avoid dealing with them.

The GrandVision saga revealed something crucial about EssilorLuxottica's DNA: when it commits to a strategic vision, it follows through regardless of short-term pain. The company absorbed the COVID losses, managed the integration challenges, and emerged with an even more dominant position in global optical retail. Critics called it monopolistic; management called it scale.

↑ Back to Top

VII. Smart Glasses & The Meta Partnership: The Next Platform (2019–Present)

While the eyewear industry was fixated on the GrandVision drama, a quieter revolution was brewing in EssilorLuxottica's labs. EssilorLuxottica and Meta established their partnership in 2019, and have focused on two generations of Ray-Ban branded smart glasses since.

The first generation, Ray-Ban Stories, launched in 2021 to mixed reviews. For comparison, the previous generation, called Ray-Ban Stories, sold less than 300,000 units in the same time period. They were bulky, limited in functionality, and faced the same consumer skepticism that had killed Google Glass. But Del Vecchio and Mark Zuckerberg saw something others missed: the path to making smart glasses desirable wasn't through technology alone—it was through fashion.

The second generation changed everything. They use a Qualcomm Snapdragon AR1 Gen1 processor, upgrade of the cameras to 12 MP, improved audio, livestreaming to Facebook and Instagram, and Meta AI. More importantly, they looked and felt like regular Ray-Bans. The technology disappeared into the design rather than dominating it.

The numbers validated the strategy spectacularly. Revenue from sales of Ray-Ban Meta smart glasses more than tripled year over year. By early 2025, the glasses had sold over 2 million units, with EssilorLuxottica plans to vastly expand its production capacity to more than 10 million annual units by the end of 2026.

In September 2024, the partnership reached a new level. EssilorLuxottica announced today that it has extended its partnership with Meta Platforms by entering into a new long term agreement, under which the parties will collaborate into the next decade to develop multi-generational smart eyewear products. This wasn't just a supplier relationship—it was a bet on the future of computing.

Mark Zuckerberg, Founder and CEO of Meta stated: "We have the opportunity to turn glasses into the next major technology platform, and make it fashionable in the process". The Facebook founder's vision aligned perfectly with EssilorLuxottica's: glasses weren't just for vision correction or sun protection—they were the next frontier of human-computer interaction.

The latest generation of Ray-Ban Meta glasses give consumers superpowers, including the ability to make phone calls, capture and share photos and videos, listen to music, and livestream content. With AI integration, users could ask their glasses to identify objects, translate languages in real-time, or provide navigation guidance—all while looking like they're wearing ordinary Ray-Bans.

The success has attracted competition. Google, Apple, and Samsung are all reportedly developing their own smart glasses. But EssilorLuxottica has a moat none of them can easily cross: decades of experience making glasses people actually want to wear, a portfolio of iconic brands, and retail distribution that reaches billions of consumers. The technology companies need EssilorLuxottica more than EssilorLuxottica needs them—a dynamic Del Vecchio would have appreciated.

↑ Back to Top

VIII. The Business Model: How to Control an Industry

The genius of EssilorLuxottica's business model lies not in any single element but in how all the pieces reinforce each other, creating a system so comprehensive that competing against one part means competing against all of it.

Start with manufacturing. The company operates dozens of factories across Italy, China, Brazil, and the United States, producing everything from high-end titanium frames to mass-market plastic lenses. The Italian corporation further outright owns and manufactures Ray-Ban, Persol, Oliver Peoples, and Oakley. This isn't just about making products—it's about controlling quality, costs, and innovation at the source.

The brand portfolio reads like a who's who of fashion. Beyond owned brands, Luxottica licenses prescription and non-prescription sunglasses frames for many luxury and designer brands including Chanel, Prada, Giorgio Armani, Burberry, Versace, Dolce and Gabbana, Michael Kors, Coach, Miu Miu and Tory Burch. Each license agreement isn't just a revenue stream—it's a relationship that makes these fashion houses dependent on EssilorLuxottica's manufacturing expertise and retail distribution.

The retail network is perhaps the most powerful moat. Luxottica retails its products through stores that it owns, predominantly LensCrafters, Sunglass Hut, Pearle Vision, Target Optical, and Glasses.com. When you control the stores, you control what consumers see, what opticians recommend, and what prices the market will bear.

Then there's the insurance component. It also owns EyeMed, one of the largest vision health insurance providers. EyeMed covers millions of Americans, steering them toward EssilorLuxottica's retail stores and products. It's a closed loop: the company that makes your glasses also owns the store that sells them and the insurance that pays for them.

Despite not owning most of the market, the company has considerable price-setting power. It uses "spiff money", financial incentives to reward other industry players who co-operate with it, and has repeatedly driven companies that competed with it on price out of business. Independent opticians who want to carry Ray-Ban or Oakley know they need to play by EssilorLuxottica's rules.

The pricing power this creates is extraordinary. Luxottica's market power has allowed it to charge price markups of up to 1000%. A pair of glasses that costs $30 to manufacture can retail for $300 or more, with consumers accepting the price because of brand power and limited alternatives.

Innovation provides the technical moat that prevents commoditization. Essilor invests over €200m each year in research and innovation, three times more than the rest of the industry combined. This isn't just R&D spending—it's a statement that any competitor needs to match this investment just to keep pace, let alone catch up.

The model is self-reinforcing. More retail stores mean more data on consumer preferences. More data means better products. Better products mean stronger brands. Stronger brands mean more pricing power. More pricing power means more profits to invest in stores, R&D, and acquisitions. It's a flywheel that gets harder to stop with each revolution.

↑ Back to Top

IX. Technology & Innovation: Beyond Traditional Eyewear

The conference room in Charenton-le-Pont hummed with tension in early 2023. The executives gathered there weren't discussing quarterly earnings or acquisition targets—they were debating whether a glasses company should become a healthcare technology company. The answer would define EssilorLuxottica's next century.

The Stellest lens represented one path forward. Myopia has reached epidemic proportions, particularly in Asia where up to 90% of young adults in some countries are nearsighted. EssilorLuxottica's solution wasn't just corrective—it was preventive. Clinical trials showed Stellest lenses could slow myopia progression in children by up to 67%, potentially preventing millions from developing high myopia and its associated risks of blindness.

But the real revolution was happening at the intersection of traditional optics and digital technology. The company announced it would acquire Israeli startup Nuance Hearing for an undisclosed amount. This was the first major strategy shift and industry expansion for the company after Del Vecchio's 2022 death, and it accompanied reports that the firm was planning to introduce hearing aid technology into its lenses.

The Nuance Audio technology embedded hearing enhancement directly into eyeglass frames, addressing two sensory deficits with one device. For the millions who need both vision and hearing correction but resist wearing hearing aids due to stigma, this was transformative. Glasses were acceptable, even fashionable. Hearing aids were not. By combining them, EssilorLuxottica could tap into a $10 billion market while solving a genuine human problem.

Artificial intelligence was being woven into every aspect of the business. In manufacturing, AI optimized lens designs for individual prescriptions and wearing preferences. In retail, AI-powered systems recommended frames based on face shape, lifestyle, and fashion preferences. The Ray-Ban Meta glasses showcased AI's consumer-facing potential, with real-time translation, object recognition, and contextual information delivery.

The company's approach to innovation differed fundamentally from Silicon Valley's "move fast and break things" ethos. Each new technology underwent years of testing, refinement, and integration into existing products before launch. The Varilux X Series lenses, for instance, incorporated decades of wearer data and advanced mathematics to minimize distortion and maximize visual comfort—innovations invisible to consumers but revolutionary in their impact.

In 2015 Essilor and the CNRS LAAS signed a research partnership. A multidisciplinary team of researchers and engineers will research lenses and glasses with active and connected functions. This wasn't corporate R&D—it was fundamental research into how light, vision, and cognition interact.

The holy grail remained true augmented reality—overlaying digital information directly onto the wearer's field of view without bulky headsets or obvious displays. While Meta worked on the software and chips, EssilorLuxottica focused on the optics and form factor. The challenge wasn't just technical but aesthetic: how do you pack a computer into glasses people want to wear all day?

The company's innovation strategy revealed a deeper truth about its market position. By controlling both the innovation pipeline and the distribution channels, EssilorLuxottica could take bigger risks than pure technology companies. If smart glasses failed, they still sold Ray-Bans. If Nuance Audio didn't take off, they still dominated progressive lenses. This portfolio approach to innovation—funded by enormous cash flows from traditional products—created a competitive advantage no startup could match.

↑ Back to Top

X. Playbook: Lessons in Industry Domination

The acquisition of Supreme in 2024 for $1.5 billion raised eyebrows across the industry. In July 2024, EssilorLuxottica agreed to buy US streetwear brand Supreme for US$1.5 billion, expanding its brand portfolio beyond eyewear and lenses for the first time. A company built on precision optics buying a skateboard brand? The move revealed the sophisticated playbook EssilorLuxottica had perfected over decades.

First lesson: Timing is everything. Del Vecchio didn't buy Ray-Ban at its peak but at its nadir, when the brand was nearly worthless. The GrandVision acquisition closed during COVID when the sellers had no leverage. Supreme was acquired after its hype had cooled but while its cultural relevance remained intact. Buy distressed assets, not hot properties.

Second lesson: Vertical integration beats horizontal expansion. Rather than acquiring more eyewear brands, EssilorLuxottica bought the entire value chain. Manufacturing, distribution, retail, insurance—each acquisition made the others more valuable. Competitors could match any single element but not the integrated whole.

Third lesson: Brand portfolios create pricing ladders. From Armani at the top to private label at the bottom, the company offers products at every price point. A consumer might start with grocery store readers and eventually graduate to $500 Chanel frames—but they never leave the EssilorLuxottica ecosystem.

Fourth lesson: Manage regulatory scrutiny through selective compliance. The company divested stores when required, adjusted practices when challenged, but never compromised its core strategy. Like Standard Oil a century earlier, it understood that bending prevented breaking.

Fifth lesson: Technology is a means, not an end. While tech companies tried to disrupt eyewear with smart glasses, EssilorLuxottica approached it differently. Technology should enhance traditional products, not replace them. The Ray-Ban Meta glasses succeeded because they were Ray-Bans first, smart glasses second.

The financial engineering was equally sophisticated. The company maintained investment-grade credit ratings despite constant acquisitions, using cash flow from mature businesses to fund growth initiatives. A record adjusted Group net profit close to 3 billion euros and free cash flow at 2.4 billion in 2023 provided ammunition for continued expansion.

Management structure mattered too. After the Sagnières battle, the company adopted a clearer governance model with Milleri as CEO and du Saillant as deputy CEO. This wasn't the merger-of-equals fantasy but a clear hierarchy that enabled decisive action.

The ecosystem strategy extended beyond eyewear. By controlling multiple touchpoints—eye exams, insurance, retail, product—the company gathered data on hundreds of millions of consumers. This data advantage, like Amazon's in e-commerce or Google's in search, created a moat that grew wider with scale.

Perhaps most importantly, EssilorLuxottica understood that industry domination required patience. Del Vecchio spent 40 years building Luxottica before the Essilor merger. The Ray-Ban turnaround took a decade. The smart glasses partnership with Meta was signed in 2019 but didn't bear fruit until 2023. This long-term orientation, rare in public companies, enabled strategies competitors couldn't match.

↑ Back to Top

XI. Bear vs. Bull Case & Investment Analysis

The bear case against EssilorLuxottica writes itself. Regulatory scrutiny intensifies globally as governments grow concerned about market concentration. The European Commission could force divestitures. The FTC could block future acquisitions. China could demand technology transfers. Any major regulatory action could unravel the carefully constructed empire.

Direct-to-consumer disruption poses an existential threat. Warby Parker proved you could sell glasses online for $95 and build a billion-dollar business. Chinese manufacturers offer similar quality at 70% lower prices. As consumers become comfortable buying glasses online, EssilorLuxottica's retail network transforms from asset to albatross.

The smart glasses bet could prove premature. Despite early success, consumer adoption might stall. Apple or Google could leapfrog the Ray-Ban Meta partnership with superior technology. The billions invested in smart glasses could become a costly distraction from the core business.

Demographic headwinds loom. Myopia rates may be rising, but LASIK and other corrective surgeries improve annually. Gene therapy could eventually cure vision problems entirely. The addressable market might shrink even as competition intensifies.

Key person risk remains despite Del Vecchio's death. Milleri and du Saillant lack their predecessor's founder authority. A leadership crisis or strategic misstep could fragment the empire Del Vecchio spent decades building.

But the bull case is equally compelling. The group recorded a +9.8% increase in adjusted net profit at €3.1 billion at constant exchange rates, representing 11.8% of revenues in 2024. These aren't the margins of a company under threat but of one extending its dominance.

The smart glasses success suggests EssilorLuxottica chose correctly. Revenue from sales of Ray-Ban Meta smart glasses more than tripled during the first half of the year, validating the platform strategy. With production scaling to 10 million units annually, smart glasses could become a multi-billion dollar business by 2030.

Emerging markets offer enormous growth potential. Hundreds of millions of people in India, Africa, and Southeast Asia need vision correction but lack access. As these economies develop, EssilorLuxottica's global infrastructure positions it to capture disproportionate share.

The medical technology pivot opens new TAMs (Total Addressable Markets). Myopia management, hearing enhancement, and eventually biometric monitoring through smart glasses could transform EssilorLuxottica from an eyewear company to a healthcare platform.

Network effects strengthen with scale. Each additional store, brand, and insurance partnership makes the ecosystem more valuable. Competitors must replicate not just products but an entire infrastructure built over decades.

Looking at valuation, the company trades at reasonable multiples despite its dominance. The dividend yield provides income while waiting for growth initiatives to mature. The balance sheet remains strong enough to fund acquisitions or weather downturns.

↑ Back to Top

XII. Epilogue: The Future of Vision

Francesco Milleri stood where Leonardo Del Vecchio once held court, looking out from the Milanese headquarters at a city the founder couldn't have imagined when he left the orphanage in 1949. Fourth consecutive year of top line growth on track with our targets, including a strong acceleration in Q4, with all regions and businesses contributing to our momentum, followed by new record high in the Group's profits. The numbers were triumphant, but Milleri knew the real challenges lay ahead.

The smart glasses revolution was accelerating faster than anyone anticipated. Meta selling 2 million units already and planning for 10 million annually by 2026 suggested the transformation from eyewear company to technology platform was not just possible but inevitable. The question was whether EssilorLuxottica would lead this transformation or be disrupted by it.

Competition was evolving too. Chinese manufacturers were moving upmarket. Tech giants were developing their own smart glasses. Online retailers were using AI to replicate the in-store experience. The moats that protected EssilorLuxottica for decades were still formidable but no longer impregnable.

The medical future beckoned most intriguingly. With aging populations worldwide and screen time driving vision problems in younger generations, the demand for vision correction would only grow. But EssilorLuxottica's ambitions extended beyond correction to enhancement—glasses that could prevent myopia, correct hearing, monitor health, and augment reality.

The incredible work we've done with Meta, still in its early stages, has already proven to be an important milestone in our journey to making glasses the gateway to the connected world. This wasn't hyperbole but prophecy. In a world where screens were everywhere, the ultimate screen would be the one you wore on your face.

The regulatory reckoning loomed but might prove manageable. Governments needed EssilorLuxottica's infrastructure to provide vision care to aging populations. Breaking up the company could reduce efficiency and raise prices—outcomes no politician wanted to own. More likely were negotiated settlements, controlled divestitures, and behavioral remedies that preserved the core business while addressing the most egregious anti-competitive practices.

What would Del Vecchio make of his empire today? The orphan who built a global colossus from nothing might appreciate the irony: the company he created to help people see better was now determining what they saw. Every Ray-Ban frames reality. Every Varilux lens adjusts perspective. Every smart glass adds a digital layer to the physical world.

This is the ultimate power—not just controlling an industry but shaping perception itself. EssilorLuxottica doesn't just make glasses. It makes the windows through which humanity views reality. And in a world where reality itself is becoming negotiable, whoever controls the windows controls everything.

The empire of sight that began with an orphan in Milan and an engineer in Paris has become something unprecedented in corporate history: a company that touches nearly every human who needs vision correction, that defines both medical necessity and luxury desire, that bridges the physical and digital worlds. It is simultaneously a monopoly and an innovator, a healthcare provider and a fashion house, a traditional manufacturer and a technology platform.

As the sun sets over Milan, Charenton-le-Pont, and the thousands of stores, factories, and laboratories that comprise EssilorLuxottica, one truth becomes clear: the future of human vision—biological and digital, corrective and augmented—will be shaped by the empire that two unlikely visionaries built. Whether that future is utopian or dystopian depends on decisions being made right now in boardrooms and R&D labs, in regulatory offices and retail stores.

The empire of sight sees all. The question is: who watches the watchers?